Anders D Hove insider trades: OnKure Therapeutics (OKUR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anders reports to the SEC
and 5 more companies
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | OKUR | ↑ Buy | 1,129,730 | $1.85 | $2.1M | By Acorn Bioventures 2, L.P. | May 19, 2025 (4d) |
| May 15, 2025 | OKUR | ↑ Buy | 270,270 | $1.85 | $500K | Direct | May 19, 2025 (4d) |
| May 7, 2018 | INSP | ↑ Buy | 125,000 | $16.00 | $2.0M | Direct | May 9, 2018 (2d) |
| May 16, 2016 | ANAC | ↓ Sell | 353,881 | $99.59 | $35.2M | By Funds and LLC's | May 18, 2016 (2d) |
| Apr 8, 2016 | ANAC | ↓ Sell | 229,301 | $71.10 | $16.3M | By Funds and LLC's | Apr 11, 2016 (3d) |
| Dec 15, 2015 | ANAC | ↓ Sell | 900,000 | $111.25 | $100.1M | By Funds and LLC's | Dec 17, 2015 (2d) |
| Dec 11, 2015 | ANAC | ↓ Sell | 40,000 | $117.36 | $4.7M | Direct | Dec 15, 2015 (4d) |
| Nov 10, 2015 | ANAC | ↓ Sell | 100,295 | $103.60 | $10.4M | By Funds and LLC's | Nov 12, 2015 (2d) |
| Oct 6, 2015 | EDGE | ↑ Buy | 450,000 | $11.00 | $5.0M | By Funds | Oct 8, 2015 (2d) |
| Sep 26, 2014 | ANAC | ↓ Sell | 20,000 | $25.00 | $500K | By Funds | Sep 30, 2014 (4d) |
| Sep 19, 2014 | ANAC | ↓ Sell | 740,000 | $24.87 | $18.4M | By Funds | Sep 22, 2014 (3d) |
| Sep 16, 2014 | ANAC | ↓ Sell | 90,000 | $24.99 | $2.2M | By Funds | Sep 16, 2014 (0d) |
| Aug 5, 2014 | AAVL | ↑ Buy | 400,000 | $17.00 | $6.8M | By Funds | Aug 7, 2014 (2d) |
| Nov 15, 2013 | ANAC | ↓ Sell | 150,000 | $14.06 | $2.1M | By Funds and LLC's | Nov 19, 2013 (4d) |
| Sep 20, 2012 | ANAC | ↓ Sell | 19,273 | $6.30 | $121K | By Funds and LLC's | Sep 24, 2012 (4d) |
| Sep 14, 2012 | ANAC | ↓ Sell | 35,000 | $6.51 | $228K | By Funds and LLC's | Sep 18, 2012 (4d) |
| Sep 13, 2012 | ANAC | ↓ Sell | 25,177 | $6.59 | $166K | By Funds and LLC's | Sep 13, 2012 (0d) |
| Feb 2, 2011 | CHTP | ↑ Buy | 75,000 | $5.00 | $375K | By Fund | Feb 4, 2011 (2d) |
| Nov 30, 2010 | ANAC | ↑ Buy | 600,000 | $5.00 | $3.0M | By Funds | Dec 2, 2010 (2d) |
| Sep 20, 2010 | CHTP | ↓ Sell | 99,000 | $6.30 | $624K | By Fund | Sep 22, 2010 (2d) |
| Apr 27, 2010 | ALIM | ↑ Buy | 306,071 | $11.00 | $3.4M | By Funds | Apr 28, 2010 (1d) |
| Jan 21, 2010 | WHRT | ↑ Buy | 388,350 | $5.15 | $2.0M | By Fund | Jan 26, 2010 (5d) |
| Oct 23, 2006 | TRBN | ↑ Buy | 35,181 | $13.00 | $457K | By Fund | Oct 25, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OKUR insiders
Open-market trades in the last 12 months
About Anders D Hove's insider trades
Anders D Hove is an insider at OnKure Therapeutics (OKUR). Since Oct 23, 2006, Anders has reported 10 open-market purchases worth $25.5M and 13 sales worth $191.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), conversions (7 filings), other transactions (6 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OKUR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.